Antiviral interferon-beta treatment has shown positive clinical and prognostic effects in enteroviral/Coxsackievirus B persistence in single center and multicenter studies, including some evidence for effective viral elimination, however, this antiviral treatment has not proved as effective in B19V associated MC/DCM [17,61]. This evidence concerns the gene IFNB1 and familial dilated cardiomyopathy.